Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Mack

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Medical Virology|August 15, 2023
Impaired systemic nucleocapsid antigen clearance in severe COVID-19Christian Bauer, Elisabeth Mack, Véronique Hefter, et al.
Redox Biology|June 24, 2025
High-dose vitamin C as a targeted treatment for KRAS-driven cancers?Elisabeth Mack, Christian Rau, Cornelia Otet, et al.
Journal of Psychosomatic Research|March 18, 2026
Expectations are associated with psychological and biological outcomes after allogeneic hematopoietic stem cell transplantation in a prospective cohort studyStefan Salzmann, Frank Euteneuer, Philipp Lishewski, et al.
Journal of Psychosomatic Research|May 25, 2026
Corrigendum to 'Expectations are associated with psychological and biological outcomes after allogeneic hematopoietic stem cell transplantation in a prospective cohort study' [Journal of Psychosomatic Research 205 (2026) 112640]Stefan Salzmann, Frank Euteneuer, Philipp Lishewski, et al.
Oncoimmunology|May 4, 2018
High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusionVerena Nilius, Madeleine C Killer, Nina Timmesfeld, et al.
Leukemia Research|October 7, 2017
Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemiaKatharina Henkenius, Brandon H Greene, Christina Barckhausen, et al.
Leukemia|June 20, 2020
Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)Andreas Neubauer, Thomas Wiesmann, Claus F Vogelmeier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2022
ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2Paraskevi C Fragkou, Giulia De Angelis, Giulia Menchinelli, et al.
Diagnostics (Basel, Switzerland)|February 14, 2020
Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortalPhilipp Buechner, Marc Hinderer, Philipp Unberath, et al.
Leukemia|August 13, 2021
The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)Andreas Neubauer, Johannes Johow, Elisabeth Mack, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Medical Virology|August 15, 2023
Impaired systemic nucleocapsid antigen clearance in severe COVID-19Christian Bauer, Elisabeth Mack, Véronique Hefter, et al.
Redox Biology|June 24, 2025
High-dose vitamin C as a targeted treatment for KRAS-driven cancers?Elisabeth Mack, Christian Rau, Cornelia Otet, et al.
Journal of Psychosomatic Research|March 18, 2026
Expectations are associated with psychological and biological outcomes after allogeneic hematopoietic stem cell transplantation in a prospective cohort studyStefan Salzmann, Frank Euteneuer, Philipp Lishewski, et al.
Journal of Psychosomatic Research|May 25, 2026
Corrigendum to 'Expectations are associated with psychological and biological outcomes after allogeneic hematopoietic stem cell transplantation in a prospective cohort study' [Journal of Psychosomatic Research 205 (2026) 112640]Stefan Salzmann, Frank Euteneuer, Philipp Lishewski, et al.
Oncoimmunology|May 4, 2018
High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusionVerena Nilius, Madeleine C Killer, Nina Timmesfeld, et al.
Leukemia Research|October 7, 2017
Maintenance of cellular respiration indicates drug resistance in acute myeloid leukemiaKatharina Henkenius, Brandon H Greene, Christina Barckhausen, et al.
Leukemia|June 20, 2020
Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)Andreas Neubauer, Thomas Wiesmann, Claus F Vogelmeier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2022
ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2Paraskevi C Fragkou, Giulia De Angelis, Giulia Menchinelli, et al.
Diagnostics (Basel, Switzerland)|February 14, 2020
Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortalPhilipp Buechner, Marc Hinderer, Philipp Unberath, et al.
Leukemia|August 13, 2021
The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)Andreas Neubauer, Johannes Johow, Elisabeth Mack, et al.
Pageof 3